FDA researchers are moving forward with a study examining the effect of proprietary names on consumers even though the agency issued final guidance on proprietary naming best practices in December 2020. The study, which the researchers note “is the first to provide a systemic investigation of a variety of proprietary prescription drug names,” was first proposed in January 202... Read More